Aims and Scope of International Journal of Oncology
The International Journal of Oncology is a monthly peer-reviewed medical journal of oncology, published by Spandidos Publications. It was established in 1992 and the editor-in-chief is Demetrios A. Spandidos (University of Crete). According to the Journal Citation Reports, the journal has a 2021 impact factor of 5.65. Less
Key Metrics
CiteScore 

11.1
Eigenfactor 

0.01 - 0.05
Impact Factor 

5 - 10
SJR 

Q1Oncology

SNIP 

1.13
Recommended pre-submission checks
Powered by 

Topics Covered on International Journal of Oncology
International Journal of Oncology Journal Specifications
| Overview | |
| Publisher | SPANDIDOS PUBL LTD |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1992 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in International Journal of Oncology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in International Journal of Oncology
The neural stem cell‑NSCLC axis: Molecular drivers, microenvironment crosstalk and emerging therapies (Review).
- 1 Sep 2026
- International journal of oncology
Retracted] Glycyrrhetinic acid induces G1‑phase cell cycle arrest in human non‑small cell lung cancer cells through endoplasmic reticulum stress pathway.
- 1 Sep 2026
- International journal of oncology
New insights into the physiological, pathological and pharmacological roles of voltage‑gated potassium channel Kv10.1 in cancer (Review).
- 1 Sep 2026
- International journal of oncology
T‑box transcription factor 15 regulated by methyltransferase‑like 3‑mediated N6‑methyladenosine modification promotes immune escape and progression of gastric cancer by activating matrix metalloproteinase 14 transcription.
- 1 Sep 2026
- International journal of oncology
Retracted] Phenotypic characterization of human prostatic stromal cells in primary cultures derived from human tissue samples.
- 1 Sep 2026
- International journal of oncology
Glycolysis‑driven immunosuppression in gastric cancer: Metabolic crosstalk between tumor cells and the immune microenvironment (Review).
- 1 Sep 2026
- International journal of oncology
The neural stem cell‑NSCLC axis: Molecular drivers, microenvironment crosstalk and emerging therapies (Review).
- 1 Sep 2026
- International journal of oncology
Retracted] Glycyrrhetinic acid induces G1‑phase cell cycle arrest in human non‑small cell lung cancer cells through endoplasmic reticulum stress pathway.
- 1 Sep 2026
- International journal of oncology
New insights into the physiological, pathological and pharmacological roles of voltage‑gated potassium channel Kv10.1 in cancer (Review).
- 1 Sep 2026
- International journal of oncology
T‑box transcription factor 15 regulated by methyltransferase‑like 3‑mediated N6‑methyladenosine modification promotes immune escape and progression of gastric cancer by activating matrix metalloproteinase 14 transcription.
- 1 Sep 2026
- International journal of oncology
Retracted] Phenotypic characterization of human prostatic stromal cells in primary cultures derived from human tissue samples.
- 1 Sep 2026
- International journal of oncology
Glycolysis‑driven immunosuppression in gastric cancer: Metabolic crosstalk between tumor cells and the immune microenvironment (Review).
- 1 Sep 2026
- International journal of oncology